Gross Profit - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98% Market Closed
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Gross Profit Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Gross Profit
$36.5m
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Gross Profit
$17.3B
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Gross Profit
$13.2B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Gross Profit
$2.2B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Gross Profit
$3.6B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Gross Profit
$5.3B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
14%

See Also

What is MaxCyte Inc's Gross Profit?
Gross Profit
36.5m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Gross Profit amounts to 36.5m USD.

What is MaxCyte Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%

Over the last year, the Gross Profit growth was -7%. The average annual Gross Profit growth rates for MaxCyte Inc have been 16% over the past three years , 20% over the past five years .

Back to Top